A cell-penetrating bispecific antibody suppresses hepatitis B virus replication and secretion
Hepatitis B virus (HBV) represents one of the major pathogenic factor that leads to chronic liver diseases and the development of hepatocellular carcinoma (HCC). The currently approved anti-HBV drugs cannot eradicate the virus or block the development of HCC. HBV nucleocapsid consists of the hepatit...
Saved in:
Main Authors: | Chongwei Xie, Bing Zhou, Da Yao, Xin Wang, Lihong Zhong, Chuanghua Qiu, Junfang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Virus Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0168170225000073 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances and prospects of cell-penetrating peptides in tumor immunotherapy
by: Di Yang, et al.
Published: (2025-01-01) -
Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo
by: Sheng Jiang, et al.
Published: (2025-01-01) -
Guanidines Conjugated with Cell-Penetrating Peptides: A New Approach for the Development of Antileishmanial Molecules
by: João Victor Marcelino de Souza, et al.
Published: (2025-01-01) -
Tumor-specific cytosol-penetrating antibodies for antigen- and TME-dependent intracellular cargo delivery
by: Carolin Sophie Dombrowsky, et al.
Published: (2025-03-01) -
Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024-12-01)